About this trial
Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged ≥ 18 years
Patients with primary ITP according to international criteria [2], who underwent to splenectomy from 01/01/2010 to 12/31/2022.
Obtaining Informed Consent.
Disqualifiers
none
Trial population
Patients with ITP who underwent splenectomy from 01/01/2010 to 12/31/2022 will be enrolled
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
evaluation of complications' incidence after splenectomy
Determine the percentage and incidence of thrombotic, hemorrhagic and infectious complications occurring during the patient's follow-up
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: